Send it Out

genomeweb
360dx

Send it Out

Jan 25, 2011

PerkinElmer is starting up a next-generation sequencing service, reports The Boston Globe's BusinessUpdates. The company is taking a "technology-agnostic approach," says Richard Begley, the president of emerging technologies, in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Enzo Biochem Fiscal Q1 Revenues Down 21 Percent
IdentiGen Receives €1.8M R&D Grant From Irish Government
SABCS 2018 Features Molecular Diagnostics Research
Metastatic ER+ Breast Cancers Acquire HER2 Mutations to Become Treatment Resistant
Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation
Agilent Granted Motion to Amend Complaint for Lawsuit Against Twist

The Scan

Not Mentioning It

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Lost Some Value There

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Slight Budget Trim

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

This Week in PLOS

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Main menu

Send it Out

To read the full story....

Breaking News

Enzo Biochem Fiscal Q1 Revenues Down 21 Percent

IdentiGen Receives €1.8M R&D Grant From Irish Government

SABCS 2018 Features Molecular Diagnostics Research

Metastatic ER+ Breast Cancers Acquire HER2 Mutations to Become Treatment Resistant

Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation

Agilent Granted Motion to Amend Complaint for Lawsuit Against Twist

The Scan

Not Mentioning It

Lost Some Value There

Slight Budget Trim

This Week in PLOS

Sponsorships